Clinical significance of breakthrough phenomenon in liver transplant patients with recurrent hepatitis C treated with Interferon-ALPHA and Ribavirin.

被引：0
|
作者：
Nasir, A [1 ]
Smallwood, GA [1 ]
Stieber, AC [1 ]
Heffron, TG [1 ]
De Vera, ME [1 ]
机构：
[1] Emory Univ Hosp, Atlanta, GA 30322 USA
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
418
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [1] Thyroid abnormalities in patients with chronic hepatitis C treated with interferon-alpha and ribavirin.
    Johnson, A
    Abrams, GA
    Fallon, MB
    Langner, RG
    van Leeuwen, DJ
    McGuire, BM
    Bloomer, JR
    [J]. HEPATOLOGY, 2000, 32 (04) : 558A - 558A
  • [2] Treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon and ribavirin.
    Samuel, D
    [J]. HEPATOLOGY, 2003, 38 (04) : 531A - 531A
  • [3] Consensus interferon in combination with ribavirin for hepatitis C patients with nonresponse or relapse to interferon alpha and ribavirin.
    Buggisch, P
    Hinrichsen, H
    Hueppe, D
    Reiser, M
    Kueppers, H
    Wursthorn, K
    Sterneck, M
    [J]. HEPATOLOGY, 2001, 34 (04) : 590A - 590A
  • [4] Treatment of recurrent hepatitis C after liver transplantation with alpha-2B interferon plus ribavirin.
    Ghalib, R
    Pandula, R
    Kadhim, TJ
    Clark, C
    Ankoma-Sey, V
    Fouzia, S
    Stribling, RJ
    Goss, JA
    Seu, P
    [J]. HEPATOLOGY, 2000, 32 (04) : 291A - 291A
  • [5] Treatment of Recurrent Hepatitis C after Liver Transplantation with PEG-Interferon and Ribavirin.
    Antonino, Anca-Teodora
    Fontana, Massimiliano
    Gioastra, Emiliano
    Moradpour, Darius
    Pascual, Manuel
    [J]. LIVER TRANSPLANTATION, 2011, 17 (06) : S149 - S149
  • [6] Decreased production of interferon-γ in patients with chronic hepatitis C treated with ribavirin in combination with interferon-alpha
    Cepparulo, M
    Bergamini, A
    Bolacchi, F
    Demin, F
    Uccella, I
    Bongiovanni, B
    Capozzi, M
    Ombres, D
    Angelico, F
    Luiti, A
    Hurtovà, M
    Francioso, S
    Angelico, M
    Rocchi, G
    [J]. JOURNAL OF HEPATOLOGY, 2000, 32 : 102 - 102
  • [7] Characteristics of Graves' Disease in a Cohort of Chronic Hepatitis C Patients Treated With Interferon-alpha and Ribavirin
    Tran, Huy A.
    Reeves, Glenn Em
    [J]. JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2011, 1 (01) : 14 - 20
  • [8] Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin - A review
    Oliveira Andrade, Luis Jesuino de
    Atta, Ajax Merces
    D'Almeida, Argemiro, Jr.
    Parana, Raymundo
    [J]. BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (02): : 144 - 148
  • [9] Preliminary treatment results of liver transplant recipients with recurrent hepatitis C virus nonresponsive to interferon alpha2B and ribavirin using combination pegylated interferon alpha 2B with ribavirin.
    Neff, GW
    Montalbano, M
    Lee, YM
    Slapak, G
    Safdar, K
    Morrero, R
    Nery, J
    Weppler, D
    Demodina, M
    Schiff, E
    Tzakis, A
    [J]. HEPATOLOGY, 2002, 36 (04) : 183A - 183A
  • [10] Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia
    Hofer, Harald
    Gurguta, Calin
    Bergholz, Ulrike
    Steindl-Munda, Petra
    Ferenci, Peter
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (19-20) : 595 - 600
12345